ANCO’s ASCO22 Highlights  will summarize the major research and treatment advancements presented at this year’s ASCO22 Annual Meeting. The program will focus on breast, developmental therapeutics, gastrointestinal, genitourinary, gynecologic,  lung cancers and melanoma, as well as a Plenary: Advancing Equitable Cancer Care Through Innovation. The faculty will place these developments in context as to their...

Join ASH on September 2-3, at the Hilton Chicago or virtually, for the 2022 ASH Meeting on Hematologic Malignancies. This year's meeting will feature top experts in the field presenting the latest clinical research, interactive question and answer session, and opportunities to interact with colleagues in an intimate, small group setting with no competing sessions....

The faculty will present the latest research on treatment modalities for hematologic malignancies—leukemias, lymphomas, and myeloma—along with case studies for these diagnoses. The program takes place in : Sacramento on September 17th San Francisco on November 12th Registration and continental breakfast will be available at 8:00 am; presentations begin at 9 am. The program will...

PRESENTATIONS Contemporary Indications for Radical Prostatectomy: Can We Make It a Better Operation? Peter Carroll, MD, MPH Urologic cancer surgeon; Professor, UCSF Department of Urology; Ken and Donna Derr – Chevron Distinguished Professor; Taube Family Distinguished Professor in Urology, UCSF Helen Diller Family Comprehensive Cancer Center Learning objectives After completing this course, attendees will have improved their skills and strategies for:...

https://cvent.me/Y1vam0 ANCO and MOASC are collaborating on a Precision Oncology Symposium on November 5 at the InterContinental Hotel in San Francisco. Precision oncology promises to improve the outcomes of patients through broad molecular diagnostic profiling and individualized treatment recommendations. Recent FDA approvals of new cancer treatments that are based on molecular tumor features and not disease type underscore the...

The faculty will present the latest research on treatment modalities for hematologic malignancies—leukemias, lymphomas, and myeloma—along with case studies for these diagnoses. The program takes place in San Francisco on November 12th Registration and continental breakfast will be available at 8:00 am; presentations begin at 9 am. The program will conclude by 12:30pm. ANCO acknowledges...

As new clinical data continues to emerge as a result of ongoing research in breast cancer diagnostics and therapeutics, official Best of SABCS® programs cover these important developments in each of the live, regional events. Each regional event provides an educational forum for local researchers and clinicians to discuss the most pertinent basic, translational, and...

THIS EVENT IS NOT SPONSORED OR PLANNED BY ANCO Date & Location Saturday, February 11, 2023, 8:00 AM - 4:00 PM PST, Ritz-Carlton, Half-Moon Bay, CA Overview The Steven Coutre Review of the 64th Annual American Society of Hematology Meeting will highlight cutting-edge research and data on hematologic disorders as well as provide participants with updated...

This conference will present the most current information on multidisciplinary approaches in clinical oncology and will consist of tumor board cases on breast, , gastrointestinal, genitourinary,  hematologic malignancies, lymphoma, and thoracic cancers. The tumor board cases will be presented by faculty, with discussion by a panel of surgical, radiation, and medical oncologists from Stanford, UC...

ANCO's Hematologic Malignancies Update 2023 will take place May 6th & 7th at the Hyatt Regency Monterey Bay, The faculty will present the latest research on treatment modalities for hematologic malignancies—leukemias, lymphomas, and myeloma—along with case studies for these diagnoses. Program Information and Registration: https://cvent.me/mPEbny Make your hotel reservation now! https://www.hyatt.com/en-US/group-booking/MRYDM/G-HEMA